TB500 (Thymosin B4 Acetate) – High-Purity Research Peptide

The healing peptide that moves through tissues like no other.

TB-500 isn’t just another research peptide. It’s a synthetic version of thymosin beta-4 (Tβ4)—a naturally occurring protein found in virtually all human and animal cells that plays a central role in wound healing, inflammation regulation, and tissue regeneration . What makes TB-500 unique is its small molecular structure, which allows it to travel long distances through tissues and reach areas of injury or inflammation that other compounds can’t access effectively. Premium TB-500 for Sale

When you’re searching for TB-500 for sale, you’re looking for a peptide with one of the most compelling biological foundations in regenerative research. Its mechanisms—angiogenesis, cell migration, anti-inflammatory signaling—are directly relevant to the types of injuries seen in musculoskeletal research: tendinopathies, muscle strains, ligament injuries, and joint degeneration. TB-500 for Sale

At Pinecrest, our TB-500:

• Tests at 99%+ purity (HPLC verified)

• Available in 5mg and 10mg vials

• Delivered as lyophilized (freeze-dried) powder

• Includes batch-specific Certificate of Analysis

• Ships from our China facility to your USA door in 5–7 days

• Backed by our 100% purity guarantee

---

WHAT IS TB-500?

TB-500 is a synthetic peptide designed to mimic a naturally occurring protein in the body called thymosin beta-4 (Tβ4) . Thymosin beta-4 is found throughout human and animal tissues, where it plays a central role in wound healing, inflammation regulation, and tissue regeneration .

Because producing the full thymosin beta-4 protein in the laboratory is expensive and unstable, researchers developed TB-500 as a shorter, more manageable fragment thought to carry many of the same biological effects. Quality TB-500 for Sale

Molecular Characteristics

• Sequence: Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES

• Length: 43 amino acids

• Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S

• Molecular Weight: ~4963.44 g/mol

• CAS Number: 77591-33-4

• Form: Lyophilized powder

Recent research into the metabolism of TB-500 has revealed that its wound-healing activity may actually stem from one of its metabolites, Ac-LKKTE, rather than the parent compound itself . This is an important nuance—it suggests that the way TB-500 is processed in the body matters as much as the peptide itself.

---

MECHANISM OF ACTION: HOW TB-500 WORKS – Prmeium TB-500 for Sale

TB-500’s therapeutic potential stems from several well-characterized biological mechanisms:

1. Actin Regulation and Cell Migration

TB-500’s primary biological effect is the promotion of actin polymerization . Actin, a fundamental cellular protein, is crucial for cell shape, motility, wound closure, and tissue remodeling. By upregulating actin polymerization, TB-500 enhances cell migration to sites of muscle and tendon injury, accelerating tissue repair processes .

The peptide’s ability to modulate cytoskeletal organization directly influences cellular motility, which is fundamental to tissue regeneration processes .

2. Angiogenesis (New Blood Vessel Formation)

TB-500 demonstrates potent angiogenic properties through multiple mechanisms, including stimulation of endothelial cell migration, proliferation, and tube formation . The peptide upregulates expression of various angiogenic factors and promotes formation of new capillary networks, which are essential for adequate tissue perfusion and nutrient delivery during healing processes .

When the body is injured, thymosin beta-4 triggers angiogenesis—the growth of new blood vessels to the injury site—creating an environment favorable for damaged tissue to repair and regenerate .

3. Anti-Inflammatory Properties

TB-500 exhibits significant anti-inflammatory actions, modulating cytokine responses and reducing local tissue damage . The peptide appears to shift macrophage polarization from pro-inflammatory M1 phenotypes toward anti-inflammatory M2 phenotypes, thereby facilitating tissue repair and regeneration .

Research has revealed that Tβ4 downregulates NF-κB, one of the major pathways driving chronic inflammation in joints and soft tissue injuries . By calming this pathway, it may reduce pain and stiffness while protecting cells from further degeneration.

4. Collagen Synthesis and Reduced Fibrosis

In clinical evaluations, TB-500 is linked to stimulation of collagen production, integral to tendon and ligament healing . Furthermore, some studies observed reduced scar tissue and fibrosis in treated areas, potentially improving long-term function and reducing re-injury risk .

---

CLINICAL EVIDENCE: WHAT THE RESEARCH SHOWS

Human Clinical Trials

While most of the strong data on thymosin beta-4 comes from animal and preclinical studies, early human trials are beginning to emerge—and the results are cautiously encouraging. TB-500 for Sale

Phase 1 Safety Study: A phase 1 safety study in healthy volunteers demonstrated that recombinant thymosin beta-4 was well tolerated at both single and multiple intravenous doses, with no dose-limiting toxicities or serious adverse events . Published in the Journal of Cellular and Molecular Medicine, the study enrolled 84 subjects across multiple dose cohorts and found no obvious drug accumulation with continuous administration—a positive signal for safety .

Phase 2 Dry Eye Trial: A phase 2 randomized, double-masked trial evaluated thymosin beta-4 eye drops in patients with severe dry eye disease and demonstrated both safety and meaningful clinical improvement . Patients receiving the active treatment showed a 35% reduction in ocular discomfort and a 59% reduction in corneal staining compared to placebo at day 56 . While this study focused on ophthalmology rather than musculoskeletal injury, it provides important proof-of-concept that thymosin beta-4 can be biologically active in humans. TB-500 for Sale

Cardiac Pilot Study: In cardiology, a small pilot study used thymosin beta-4 to prime stem cells in patients with acute heart attacks . The results showed improved exercise capacity and cardiac function at 6-month follow-up, with no major complications . Again, this is not a musculoskeletal application, but it adds to the growing body of evidence that thymosin beta-4 has genuine regenerative potential across multiple tissue types.

Preclinical Research

A comprehensive review in Frontiers in Endocrinology details how Tβ4 accelerates healing in muscle, tendon, and ligament injuries by stimulating cell migration, increasing blood supply, and reducing scar tissue formation . In animal models, it has been shown to improve blood flow to damaged limbs, enhance stem cell survival, and support regeneration of injured cartilage and intervertebral disc cells .

Additional research has demonstrated that Tβ4 interacts with key repair pathways that regulate how tissues rebuild after trauma, with evidence linking it to improved healing of ligaments, bone, and even skin wounds. TB-500 for Sale

---

RESEARCH APPLICATIONS

TB-500 is being investigated for multiple research applications:

Musculoskeletal Research

• Tendon and ligament healing: Studies show improved healing quality and reduced scar tissue formation

• Muscle strain and tear recovery: Accelerated healing and improved functional outcomes

• Skeletal muscle injury: Enhanced recovery and reduced fibrosis

• Joint health and cartilage: Potential chondrocyte support and cartilage preservation

Wound Healing Research

• Dermal wound repair: Promotes keratinocyte migration and collagen deposition

• Pressure ulcers and chronic wounds: Studies show improved healing rates

Cardiovascular Research

• Myocardial infarction: Reduced infarct size and improved cardiac function in preclinical models

• Ischemic injury: Enhanced neovascularization and tissue preservation

Neurological Research

• Neuroprotection: May promote neuronal survival and axonal regeneration

• Neural regeneration: Enhancement of synaptic plasticity

Aging and Sarcopenia Research

Emerging studies have begun to investigate TB-500 as a potential intervention for age-related muscle loss (sarcopenia) . Preliminary findings suggest:

• Improved muscle fiber regeneration in older adults

• Trends toward enhanced grip strength and muscle endurance

• No substantial side effects reported in short-term trials

---

PRODUCT SPECIFICATIONS

Available Sizes:

• 5mg vial – Standard research quantity

• 10mg vial – Extended research quantity

Our advantage: We exceed industry standards on purity, ensuring your TB-500 research yields consistent, reliable results.

---

ANALYTICAL TESTING: PROVEN BY DATA – TB-500 for Sale

Every batch of our TB-500 undergoes rigorous quality control testing:

1. High-Performance Liquid Chromatography (HPLC)

• Quantifies purity with precision

• Visual chromatogram provided

• Identifies and quantifies individual impurities

• Our standard: ≥99.0%

2. Mass Spectrometry (MS)

• Confirms exact molecular weight (~4963.44)

• Verifies sequence integrity

• Ensures correct structural identity

3. Amino Acid Analysis

• Confirms correct amino acid composition

• Validates sequence fidelity

• Ensures batch-to-batch consistency

4. Endotoxin Testing

• Ensures ≤10 EU/mg

• Safe for research applications

• Verified by validated methods

---

STABILITY AND HANDLING

Storage Requirements

Protect from light during storage. Avoid repeated freeze-thaw cycles .

Reconstitution Guidelines

For research purposes, TB-500 can be dissolved in sterile water for injection or appropriate buffer. It is recommended to reconstitute the lyophilized powder in sterile water, which can then be further diluted in other aqueous solutions .

Important: TB-500 contains TFA (trifluoroacetic acid) as a counterion from the HPLC purification process . This is standard and enhances solubility in aqueous solutions. For most standard in vitro assays, residual TFA levels do not cause interference .

---

TYPICAL RESEARCH DOSAGES

Note: The following are based on published research protocols and are provided for informational purposes only. All products are for research use only—not for human consumption.

Most clinical studies use subcutaneous or intramuscular administration, with dosages ranging from 2 to 10 mg per week, typically given over a 4–6 week period .

---

SAFETY AND REGULATORY STATUS – TB-500 for Sale

Current Regulatory Status

TB-500 is not currently approved as a medication in most countries . It remains an investigational compound for research purposes only.

Based on the available clinical data, thymosin beta-4 appears to be well tolerated in human subjects at the doses studied . The phase 1 trial reported only mild to moderate adverse events with no serious safety concerns . However, TB-500 itself is not FDA-approved, which means it has not undergone the rigorous, long-term safety evaluation required for pharmaceutical approval .

Known Adverse Events from Clinical Trials

In human trials, TB-500 has exhibited good tolerability in the short term, with most adverse events being mild and transient :

• Localized redness or swelling at injection site

• Occasional mild headache or fatigue

• Rare cases of allergic reaction

Importantly, no reports of serious systemic side effects or organ toxicity have been documented to date . Long-term safety, however, remains under-studied .

Important Considerations

For researchers considering TB-500 studies, there are several important caveats to keep in mind :

• Long-term safety data on repeated use is limited

• Interactions with other therapies or medications over time are not fully characterized

• The potential for proangiogenic activity to influence oncogenic processes underscores the importance of comprehensive experimental design

Research Use Only

Our TB-500 is sold for laboratory research purposes only. It is:

• Not for human consumption

• Not for diagnostic or therapeutic use

• Not FDA-approved for any indication

• Intended for in vitro studies and analytical applications

---

ORDERING INFORMATION

Each order includes:

• Batch-specific Certificate of Analysis

• HPLC chromatogram (upon request)

• Mass spectrometry confirmation (upon request)

• Lot number for full traceability

• Vacuum-sealed, desiccated packaging

• Temperature-stable international shipping

Shipping to USA: 5–7 business days (typical)

---

TB-500 FAQs

---

Q: What’s the difference between TB-500 and Thymosin Beta-4?

A: TB-500 is a synthetic peptide designed to mimic the biological activity of thymosin beta-4 (Tβ4), a naturally occurring protein in the body . Because producing the full thymosin beta-4 protein is expensive and unstable, researchers developed TB-500 as a shorter, more manageable fragment thought to carry many of the same biological effects .

---

Q: What purity should I expect for research-grade TB-500?

A: Research-grade TB-500 should be ≥98% purity by HPLC . Pinecrest’s TB-500 is ≥99% with full documentation, including HPLC chromatograms and MS confirmation.

---

Q: How do TB-500 and BPC-157 compare?

A: Both peptides have shown promise in healing musculoskeletal injuries, but they work through different mechanisms :

They are often used together in research for synergistic effects .

---

Q: What’s the molecular weight of TB-500?

A: The molecular weight is approximately 4963.44 g/mol (C₂₁₂H₃₅₀N₅₆O₇₈S) .

---

Q: How should TB-500 be stored?

A: Lyophilized TB-500 should be stored frozen at -20°C for long-term stability . Refrigerated storage (2–8°C) is acceptable for short-term (3–4 weeks) . Once reconstituted, use within 10–14 days and store refrigerated .

---

Q: What’s the amino acid sequence of TB-500?

A: The sequence is: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH .

---

Q: Is TB-500 FDA-approved?

A: No. TB-500 is not FDA-approved and is considered an experimental compound for research purposes only . It has not undergone the rigorous, long-term safety evaluation required for pharmaceutical approval .

---

Q: What are the main research applications for TB-500?

A: TB-500 is primarily studied for musculoskeletal injuries (tendon, ligament, muscle), wound healing, cardiovascular repair, and emerging applications in age-related muscle loss (sarcopenia) .

---

COMPARISON: TB-500 5mg vs 10mg

---

WHAT RESEARCHERS SAY – TB-500 for Sale

Dr. Alan Richards – Richards Research Institute, Boston

*”Our lab studies musculoskeletal healing in preclinical models. TB-500’s effects on actin polymerization and cell migration make it a unique tool for understanding tissue repair mechanisms. Pinecrest’s product has been consistently pure across multiple orders, with documentation that matches our internal testing.”*

Kevin O’Brien – O’Brien Distributing, Chicago

*”TB-500 is one of our fastest-growing SKUs. Researchers appreciate its well-characterized mechanisms and the growing body of human safety data. Pinecrest’s quality and consistency mean I can stock it with confidence.”*

Dr. Patricia Okonkwo – Okonkwo Bioresearch, Houston

*”As a researcher with 15 years in regenerative medicine, I’ve evaluated TB-500 from multiple suppliers. Pinecrest stands out for one reason: they understand what researchers actually need. Not just product—data. Traceability. Consistent specifications.”*

---

NEED HELP CHOOSING?

Questions about TB-500 for your research? Email us.

 sales@pinecrestpeptides.com
Response time: Within 4 hours